The company stated that they are prepared to begin shipping product to wholesalers in early February 2018. Upsher-Smith Laboratories has received approval from the Food and Drugs Administration (FDA) ...

Credit: Aptar Pharma. Enbumyst is supplied in a unit-dose nasal spray containing bumetanide 0.5 mg per 0.1 mL. Enbumyst is not intended for chronic use and should be replaced with oral diuretics as ...

Britons taking a specific medication are being urged to observe a 4pm rule. Failing to follow this advice could lead to sleep disturbances. Bumetanide is part of a drug category called diuretics, ...

Brits prescribed a particular medicine are being advised to adhere to a 4pm deadline. Ignoring this guidance could result in disrupted sleep. Bumetanide belongs to a class of drugs known as diuretics, ...

Enbumyst is not intended for chronic use and should be replaced with oral diuretics as soon as practical. The Food and Drug Administration (FDA) has approved Enbumyst ™, a nasal spray formulation of ...